Inhaled Iloprost for Severe Pulmonary Hypertension
Top Cited Papers
- 1 August 2002
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (5) , 322-329
- https://doi.org/10.1056/nejmoa020204
Abstract
Uncontrolled studies suggested that aerosolized iloprost, a stable analogue of prostacyclin, causes selective pulmonary vasodilatation and improves hemodynamics and exercise capacity in patients with pulmonary hypertension.Keywords
This publication has 28 references indexed in Scilit:
- Ultrasonicversusjet nebulization of iloprost in severe pulmonary hypertensionEuropean Respiratory Journal, 2001
- Effects of Iloprost Inhalation on Exercise Capacity and Ventilatory Efficiency in Patients With Primary Pulmonary HypertensionCirculation, 2000
- A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertensionJournal of the American College of Cardiology, 2000
- Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996
- Caution with use of inhaled nitric oxideThe Lancet, 1996
- Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Rebound pulmonary hypertension on withdrawal from inhaled nitric oxideThe Lancet, 1995
- Aerosolised prostacyclin in adult respiratory distress syndromeThe Lancet, 1993